The Effect of ACT-Based Nursing Interventions on Social Cognition, Emotion Regulation and Psychol… (NCT07661225) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
The Effect of ACT-Based Nursing Interventions on Social Cognition, Emotion Regulation and Psychological Flexibility in Patients With Schizophrenia
64 participantsStarted 2026-10
Plain-language summary
This randomized controlled trial aims to evaluate the effect of Acceptance and Commitment Therapy (ACT)-based nursing interventions on social cognition, emotion regulation, and psychological flexibility in individuals diagnosed with schizophrenia. The study will be conducted at Erzincan Community Mental Health Center (TRSM) between October 2026 and January 2027. A total of 64 participants (32 experimental, 32 control) will be recruited from schizophrenia patients registered at the center. The experimental group will receive 8 structured group sessions based on ACT principles integrated into nursing practice (45-60 minutes per session, once weekly), while the control group will receive routine care only. Pre-test and post-test measurements will be obtained using the Observable Social Cognition Rating Scale (OSCARS), the Difficulties in Emotion Regulation Scale-Brief Form (DERS-16), and the Acceptance and Action Questionnaire-II (AAQ-II).
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Diagnosed with schizophrenia (ICD-10/DSM-5) and followed at Erzincan Community Mental Health Center (TRSM)
* Registered at Erzincan TRSM
* Duration of schizophrenia diagnosis of at least 6 months
* No cognitive or sensory (hearing/visual) deficit that would prevent participation
* Literate
* Provides written informed consent to participate
Exclusion Criteria:
* Comorbid psychiatric diagnosis other than schizophrenia
* Active acute psychotic episode at enrollment
Discontinuation / Withdrawal Criteria
* Voluntary withdrawal from the study
* Acute psychotic relapse during the study period
* Additional psychiatric diagnosis during the study period
* Radical change in medication type or dosage during the study period
* Incomplete responses on data collection forms
* Completion of less than 80% of assigned homework
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Social Cognition
Timeframe: Baseline (before Session 1, Week 0) and immediately following Session 8 (Week 8)
2
Emotion Regulation
Timeframe: Baseline (before Session 1, Week 0) and immediately following Session 8 (Week 8)
3
Psychological Flexibility
Timeframe: Baseline (before Session 1, Week 0) and immediately following Session 8 (Week 8)